玻尿酸的全球市场 - 市场规模，占有率，成长分析，各用途 - 产业预测(2023年～2030年)

Global Hyaluronic Acid Market Size, Share, Growth Analysis, By Application(Dermal Fillers, Osteoarthritis) - Industry Forecast 2023-2030

出版日期: 2023年07月20日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球玻尿酸的市场规模将从2022年的94亿美元到2030年达到168亿美元，在预测期间(2023年～2030年)时将以年复合成长率7.58％的速度成长。

在化妆品和医疗保健行业需求不断增长的推动下，全球透明质酸市场正在稳步增长。透明质酸是一种存在于人体内的天然物质，广泛用于护肤品、真皮填充剂和关节治疗。人们越来越认识到透明质酸在维持皮肤健康和减少衰老迹象方面的好处，这推动了市场的扩张。技术进步和研发活动进一步促进了市场的增长潜力。

促进因素

整形外科医生和美容诊所的激增促使进行美容手术的数量增加。对肉毒桿菌和透明质酸注射剂等非手术美容手术的需求不断增长，正在推动透明质酸行业的发展。

阻碍因素

然而，由于竞争加剧以及神经?胺和维生素C 等其他护肤化合物的日益普及，透明质酸市场面临挑战。此外，严格的法规，特别是有关皮肤和护髮产品的法规，可能会在可预见的未来阻碍市场的增长

趋势

透明质酸市场将受益于两个普遍趋势：老年人口的增加和肥胖患病率的上升。

本报告提供全球玻尿酸市场相关调查分析，提供市场动态及预测，市场区隔分析，企业简介等资讯。

Allergan plc
Anika Therapeutics, Inc.
Ferring Pharmaceuticals
Galderma S.A.
Genzyme Corporation
Hyaltech Ltd.
LG Life Sciences Ltd.
Medytox, Inc.
Merz Pharma GmbH & Co. KGaA
Salix Pharmaceuticals, Inc.
Sanofi S.A.
Seikagaku Corporation
Shanghai Jingfeng Pharmaceutical Co., Ltd.
Shiseido Company, Limited
Sinclair Pharma plc
Smith & Nephew plc
Teva Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals International, Inc.
Zimmer Biomet Holdings, Inc.
AstraZeneca

简介目录

Product Code: SQSG15E2026

Hyaluronic Acid Market size was valued at USD 8.74 billion in 2021 and is poised to grow from USD 9.4 billion in 2022 to USD 16.8 billion by 2030, growing at a CAGR of 7.58% in the forecast period (2023-2030).

The global hyaluronic acid market is experiencing steady growth, driven by increasing demand from the cosmetic and healthcare sectors. Hyaluronic acid, a natural substance found in the human body, is widely used in skincare products, dermal fillers, and joint treatments. The rising awareness about the benefits of hyaluronic acid in maintaining skin health and reducing signs of aging is fueling market expansion. Technological advancements and research and development activities are further contributing to the market's growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of Hyaluronic Acid and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Hyaluronic Acid Marketis segmented on the basis of application and region. Based on application, the Hyaluronic Acid Market is segmented into Dermal Fillers, Osteoarthritis, Ophthalmic, and Vesicoureteral Reflux. Based on region, the global Hyaluronic acid market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The proliferation of plastic surgeons and cosmetic clinics has led to an increase in the number of aesthetic operations being performed. The growing demand for nonsurgical cosmetic procedures, such as Botox and hyaluronic acid injectables, is driving the hyaluronic acid industry.

Restrain

However, the hyaluronic acid market faces challenges due to rising competition and the growing popularity of other skincare compounds like ceramides and vitamin C. Additionally, strict regulations, particularly regarding skin and hair care products, could hinder the market's growth in the foreseeable future

Trend

The hyaluronic acid market stands to benefit from two prevailing trends: the increasing elderly population and the rising prevalence of obesity. Dermal fillers, particularly those made from hyaluronic acid, are the most commonly used nonsurgical injectable procedures for addressing facial soft tissue abnormalities, as reported by the American Society of Plastic Surgeons (ASAPS). These fillers are utilized to smoothen wrinkles and creases, treat under-eye dark circles, minimize scars, and rejuvenate the skin. These advancements are expected to drive the expansion of the hyaluronic acid market and sustain its growth throughout the projected period.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Hyaluronic Acid Market by Application
- Market Overview
- Dermal Fillers
- Osteoarthritis
- Ophthalmic
- Vesicoureteral Reflux
Global Hyaluronic Acid Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Allergan plc
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Anika Therapeutics, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ferring Pharmaceuticals
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Galderma S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Genzyme Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Hyaltech Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LG Life Sciences Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medytox, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merz Pharma GmbH & Co. KGaA
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Salix Pharmaceuticals, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Seikagaku Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Shanghai Jingfeng Pharmaceutical Co., Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Shiseido Company, Limited
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sinclair Pharma plc
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Smith & Nephew plc
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Teva Pharmaceutical Industries Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Valeant Pharmaceuticals International, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Zimmer Biomet Holdings, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AstraZeneca
Company Overview
Business Segment Overview
Financial Updates
Key Developments